The Future Of Interoperability: Leveraging AI To Improve Care And Reduce Administrative Burdens [Forbes]
ARKEMA S/ADR (ARKAY)
NASDAQ:AMEX Investor Relations:
arkema.com/en/investor-relations
Company Research
Source: Forbes
Making Intelligent Interoperability A Reality Across Healthcare Physicians currently deal with two core data challenges: access and overload. Even when doctors are able to access patient data from other systems, pinpointing and extracting the most relevant information for a particular patient's case can require tremendous effort. AI-driven intelligent interoperability addresses these challenges. AI processes a huge volume of disparate healthcare data quickly and accurately, finding patterns in this information to help optimize clinical workflows. That — along with structuring that data and adding it to the patient's health record -— reduces the administrative burden on doctors and gives them more time to focus on patient care. Unlike traditional on-premise EHRs, athenaOne — a modern, AI-native EHR system — is anchored in intelligent interoperability. The platform uses AI to synthesize clinical information from different systems and accelerate real-time data exchange, creating a
Show less
Read more
Impact Snapshot
Event Time:
ARKAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARKAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARKAY alerts
High impacting ARKEMA S/ADR news events
Weekly update
A roundup of the hottest topics
ARKAY
News
- Arkema (OTCMKTS:ARKAY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Arkema: Statement About the Number of Shares and Voting Rights in Compliance with the Article L.233-8 II of the French Commercial Code and the Article 223-16 of the Financial Markets Authority (AMF-Autorité des Marchés Financiers)Business Wire
- Arkema and Semcorp Sign a Strategic Partnership in Battery SeparatorsBusiness Wire
- Arkema: Guidance Cut Priced In, Risk-Reward Turning More Attractive [Seeking Alpha]Seeking Alpha
- Arkema (OTCMKTS:ARKAY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.MarketBeat